JP2019036065A - Chemotherapy assistance device and chemotherapy assistance program - Google Patents

Abstract

To provide a chemotherapy assistance device and a chemotherapy assistance program, by which an administration schedule can be made even though a doctor does not grasp a regimen correctly.SOLUTION: A chemotherapy assistance device 1 stores, in storage means, regimen mater information including regimen information and overlapping information. The regimen information is information indicating a regimen including a type of anticancer agent to be administered to a patient, a standard amount of administration and an administration schedule. The overlapping information is information indicating whether or not a combination with other anticancer agent different from the anticancer agent used in the regimen information is permitted. In the chemotherapy assistance device 1, if a combination with other anticancer agent arises in a period of an administration schedule prescribed by the regimen information when a regimen order is formed based on the regimen information, order processing means determines based on the overlapping information whether or not to permit overlapping. Therefore, without relying on a memory and an experience of a doctor, a correct determination can be made.SELECTED DRAWING: Figure 1

Description

  The present invention relates to a chemotherapy support apparatus and a chemotherapy support program for supporting a doctor who performs cancer treatment using an anticancer drug.

  For cancer treatment, chemotherapy using an anticancer agent is known. Drugs as well as anticancer drugs have a direct effect on the body if the dosage is incorrect. In particular, the dosage is important because anticancer agents act radically on the body. A technique for checking such a dosage is known (for example, see Patent Document 1).

  The “drug dosage check device and drug dosage check method” described in Patent Document 1 is configured such that when administration schedule data of the body weight of a person who administers a drug is input through the input unit, the control unit controls the drug and its drug administration. Based on the dose, planned dosing data, and past performance data called from the database, it is determined whether the drug dose of the drug to be administered is outside the drug dose tolerance range recorded in the database. When it is determined that the drug dose is outside the allowable range of the drug dose recorded in the database, the notification unit notifies that it is “inappropriate”.

JP, 2006-181134, A

In the drug dose check device described in Patent Document 1, the dose is checked, but the combination with other drugs is not considered.
On the other hand, in chemotherapy, the type of drug administered to a patient, the standard dose, and the administration schedule are determined by the regimen master. Then, based on this regimen master, it is changed to the content suitable for the patient, and the regimen is ordered for treatment.
However, it is difficult for a doctor to grasp the entire contents of the regimen and assemble a dosing schedule for the patient.

  Therefore, an object of the present invention is to provide a chemotherapy support apparatus and a chemotherapy support program that can plan an administration schedule even if a doctor does not accurately grasp the regimen.

  The chemotherapy support device of the present invention is a combination of anticancer agents administered to a patient, regimen information indicating a standard dose and a regimen including a dosing schedule, and other anticancer agents different from the anticancer agents used in the regimen information. In the period of the administration schedule defined by the regimen information when the regimen order is created based on the storage unit storing the regimen master information including duplicate information indicating whether or not to allow the regimen, Order processing means for determining whether or not duplication is allowed based on the duplication information when a combination with another anticancer agent occurs is provided.

  The chemotherapy support program of the present invention is different from the anticancer agent used in the regime information indicating the type of anticancer agent administered to the patient, the regimen information including the standard dose and the administration schedule, and the regimen information. Storage means for storing regimen master information including duplicate information indicating whether or not a combination with an anticancer agent is allowed, and a dosage schedule defined by the regimen information when a regimen order is created based on the regimen information When a combination with another anticancer agent occurs during this period, it is made to function as an order processing means for determining whether or not duplication is allowed based on the duplication information.

  According to the present invention, when the order processing means creates a regimen order based on the regimen information, if a combination with another anticancer agent occurs during the period of the administration schedule specified by the regimen information, it is based on the duplicate information. In order to determine whether or not duplication is allowed, when duplication between regimens occurs, it is possible to accurately determine without depending on the memory and experience of a doctor.

  The duplication information includes whether or not duplication with all other regimens is permitted, or duplication availability information indicating that duplication with the regimen is selectively permitted, and the duplication availability information is selectively In the case of indicating that duplication is allowed, it is possible to provide duplication regime information indicating a regime in which duplication is allowed.

  The duplication information consists of duplication availability information and duplication regimen information, and the duplication availability information indicates whether or not duplication with all other regimens is permitted, or selectively duplication with regimens is permitted. Therefore, the order processing means can determine whether not only the overlap with other regimens is allowed or not allowed but also allowed depending on the regimen.

  According to the present invention, when there is an overlap between regimens, it is possible to accurately determine without depending on the doctor's memory and experience, so even if the doctor does not accurately grasp the regimen, the administration schedule Can be planned.

It is a figure showing composition of a chemotherapy support system concerning an embodiment of the invention. It is a figure for demonstrating the structure of the process server which functions as a chemotherapy support apparatus of the chemotherapy support system shown in FIG. It is a figure which shows an example of a regimen list screen. It is a figure which shows an example of a regimen confirmation screen. It is a figure which shows an example of a regimen order screen. It is a figure which shows an example of the warning message screen displayed when the upper limit of a dosage rate is exceeded. It is a figure which shows an example of an administration schedule screen. It is a figure which shows an example of an order registration confirmation screen. It is a figure which shows an example of an order registration completion screen. It is a figure which shows an example of a course history screen. It is a figure which shows an example of a regimen confirmation screen. FIG. 4 is a diagram showing an example of a regimen reference screen in which “Weekly docetaxel” is selected from the regimen list screen shown in FIG. 3. It is a figure which shows an example of the regimen reference screen from which "medullary note" was selected from the regimen list screen shown in FIG. It is a figure which shows an example of the regimen reference screen from which "Rituxan" was selected from the regimen list screen shown in FIG. It is a figure which shows an example of the duplication information contained in the regimen master information stored in the memory | storage means. It is a figure which shows an example of the warning message screen displayed when the duplication of courses which duplication is not accept | permitted generate | occur | produced. It is a figure which shows an example of a Day movement screen. It is a figure which shows an example of an order reference screen. It is a figure which shows an example of the confirmation screen at the time of Day movement. It is a figure which shows an example of a Day movement screen. It is a figure which shows an example of an order reference screen.

A chemotherapy support system according to an embodiment of the present invention will be described with reference to the drawings.
In the chemotherapy support system 1 shown in FIG. 1, a processing server 2 that functions as a chemotherapy support device and a plurality of terminal devices 3 operated by each doctor communicate with a LAN that is an example of an electrical communication line in a hospital H. It is connected as possible. An electronic medical chart system (not shown) and a terminal device (not shown) operated by a pharmacist at a pharmacy are connected to the LAN.
Note that the processing server 2, the terminal device 3, the electronic medical record system, and the terminal device operated by the pharmacist may be connected via a WAN. In FIG. 1, hubs and routers that are relay devices are not shown.

The processing server 2 is a computer that functions as a chemotherapy support apparatus by operating a chemotherapy program. The processing server 2 transmits screen data to the terminal device 3 by HTTP (Hypertext Transfer Protocol) according to the operation of the terminal device 3.
The terminal device 3 is, for example, a computer on which a browser that displays screen data transmitted as page data from the processing server 2 operates. The terminal device 3 has a function of transmitting input data input by operating the input means to the processing server 2.

Here, the configuration of the processing server 2 will be described in detail with reference to FIG.
The processing server 2 includes a communication unit 21, an order processing unit 22, a schedule processing unit 23, and a storage unit 24.
The communication means 21 has a function of controlling data communication with the LAN.
Based on the request from the terminal device 3, the order processing means 22 orders the regimen created from the regimen master information stored in the storage means 24 to a terminal device (not shown) operated by the pharmacist at the pharmacy. It has a function.

The schedule processing means 23 has a function of processing the display and change of the administration schedule.
The storage means 24 stores a chemotherapy program, data used by the chemotherapy program, and the like. In addition, the storage means 24 stores regimen master information including regimen information indicating a regimen including a type of drug, a dose of the drug, a dosing schedule and the like, and redundant information to be described later.

The operation and use state of the chemotherapy support system according to the embodiment of the present invention configured as described above will be described with reference to the drawings.
The doctor first sets a new order.
A new order can be set from the regimen list screen P1 (see FIG. 3) transmitted by the order processing means 22 of the processing server 2 to the terminal device 3. The regimen list screen P1 is read from the storage unit 24 by the order processing unit 22 and is generated based on the regimen master information.
The regimen list screen P1 is processed by pressing the new history / combination button B11 displayed as “new order / order history” or the list display button B12 displayed as “regimen list” located at the upper left of the screen. It is transmitted from the server 2 to the terminal device 3.

At this time, the physique information (height and weight) of the patient read from the electronic medical record system is displayed at the upper part of the regimen list screen P1, and the body surface area and the standard weight based on the physique information are displayed. In the present embodiment, as shown in FIG. 3, the height of the patient is 91.4 cm for convenience so that the body surface area is 1.000 m ² when calculated by the Du Boys formula.

  In the regimen list screen P1, a large classification column R11 is displayed on the left side, and a small classification column R12 is displayed on the right side. In the large classification column R11, “breast cancer”, “stomach cancer”, “colon / rectal cancer”, and “pancreatic / biliary tract cancer”, which are major classifications of cancer types, are displayed. When the doctor selects “breast cancer” from the major categories, a list of regimens belonging to the major category “breast cancer” is displayed in the minor category column R12. For example, it is assumed that the doctor selects the regimen name “Weekly docetaxel” and highlights it, and then presses the regimen confirmation button B13.

  When the press of the regimen confirmation button B13 is transmitted to the processing server 2, the order processing unit 22 reads information on the patient from the electronic medical record system from the storage unit 24, and displays the regimen confirmation screen P2 shown in FIG. 3 to send.

In the regimen confirmation screen P2, the physique information selection field R21 is calculated from the latest patient height, weight and body surface area read from the electronic medical chart system, the height, weight and body surface area of the previous course, and the patient height. Standard weight is displayed. In the setting of the order this time, since the course is the first time (first course), the physique information at the time of the previous course is not displayed.
In addition, on the regimen confirmation screen P2, “Weekly docetaxel” is 1 course (course) in 28 days in the regimen comment display field R22, and each week of medication is continued for 3 weeks (medication period), and the remaining 1 week It is displayed that it is a drug holiday (drug holiday). In addition, in the regimen confirmation screen P2, it is displayed in the recipe display field R23 that docetaxel intravenous infusion, which is an anticancer agent, is performed on the first day (Day 1), the eighth day (Day 8), and the 15th day (Day 15). ing.

The doctor operates the input means of the terminal device 3 and selects any physique information displayed in the physique information selection field R21.
Further, the doctor designates the number of courses in the course time designation field R24. For the first time, the first course is designated by designating “1”, for example, “Current Course No.“ 1 ”to“ 1 ””.
When the selection of the physique information and the designation of the number of courses are completed, the doctor operates the input means of the terminal device 3 and presses the regimen order button B2.

When the press of the regimen order button B2 is transmitted from the terminal device 3 to the processing server 2, the order processing means 22 transmits the regimen order screen P3 shown in FIG.
The regimen order screen P3 is a screen on which detailed information on the examination result of the patient read from the electronic medical record system is displayed at the top, and the dosage of the medicine can be set.

Similar to the administration start date setting field R31 for specifying the course start date and the regimen confirmation screen P2 (see FIG. 4), a recipe display field R32 is displayed on the regimen order screen P3.
In the recipe display field R32, a dose setting unit S31 reflected in the dose of the drug and a dose setting unit S32 for setting the dose of the drug by the unit “mg” are displayed. Furthermore, a regimen master conforming button B31 is set on the regimen order screen P3. The regimen master conforming button B31 is set to a dose and a dose based on the regimen master information.

The doctor sets the dose of the drug in the current course as “percent” in the dose setting unit S31, or sets the dose as “mg” in the dose setting unit S32. At this time, when the anticancer agent “docetaxel intravenous infusion” was 40 mg at a dose of 100%, it was changed to a dose of 45 mg.
The dose of 45 mg is approximately 112.5% (dose rate) with respect to the dose of 40 mg at a dose of 100% on the body surface area of the patient. When the order processing means 22 determines that the upper limit of the administration rate set in the storage means 24, for example, 105% is exceeded, it displays a warning message screen P31 indicating the administration rate upper limit as shown in FIG.
In this way, even if an attempt is made to make a setting that exceeds the upper limit of the administration rate, the processing server 2 checks and blocks the setting, so that a doctor's setting mistake can be prevented.

When the setting on the regimen order screen P3 shown in FIG. 5 is completed, the doctor presses the administration schedule button B32.
When the depression of the administration schedule button B32 is transmitted from the terminal device 3 to the processing server 2, the order processing means 22 transmits the administration schedule screen P4 shown in FIG.
In the administration schedule screen P4, in the recipe detail column R41, in addition to the anticancer agent, a drug administered by infusion (injection) or a drug administered by oral ingestion in the selected regimen corresponds to the effective date. Is displayed. In addition, the administration time for administration is displayed for each enforcement date.
The doctor confirms the contents of each recipe (RpNo.001 to RpNo.003), and presses the order registration button B41 if there is no problem.

When the pressing of the order registration button B41 is transmitted from the terminal device 3 to the processing server 2, the order processing means 22 displays an order registration confirmation screen P5 (see FIG. 8) for final confirmation from the doctor. Send to.
On the order registration confirmation screen P5, an OK button B51 for permitting registration and a cancel button B52 for returning to the administration schedule screen P4 shown in FIG. 7 are displayed.
Here, when the OK button B51 is pressed, the order processing means 22 stores the contents registered in the order as registration regime information in the storage means 24, and displays the order registration completion screen P6 (see FIG. 9). It transmits to the terminal device 3. The order registration completion screen P6 indicates that the first course with the regimen name “Weekly docetaxel” has been ordered.
In addition, the order processing means 22 transmits the registered regimen information in which the first course with the regimen name “Weekly docetaxel” is ordered to a terminal device (not shown) operated by the pharmacist located in the pharmacy as the regimen order. .

  When setting the next course, the user presses the new history / combination button B11 displayed as "new order / order history" located at the upper left. By this pressing, the order processing means 22 reads the course information set in the storage means 24 and transmits a course history screen P7 shown in FIG.

On the course history screen P7, it is displayed that the first course with the regimen name “Weekly docetaxel” is set from the course period “June 13, 2016” to “July 10, 2016”.
For example, when setting the second course of this regimen, the doctor presses the copy button B71. As a result of this depression, the order processing means 22 transmits a regimen confirmation screen P8 (see FIG. 11) to the terminal device 3 in the same way as the regimen confirmation screen P2 shown in FIG.

Since the previous course (first course) is set on the regimen confirmation screen P8, “2” is designated from the beginning in the course time designation field R81.
When registering the second course with the same content as the first course, press the regimen order button B8. Subsequently, following the first course according to the regimen order screen P3 (see FIG. 5), the administration schedule screen P4 (see FIG. 7), the order registration confirmation screen P5 (see FIG. 8) and the order registration completion screen P6 (see FIG. 9). Second course can also be set.

When it is desired to order the second course with a new regimen on the course history screen P7 shown in FIG. 10, the new order button B72 is pressed.
When the new order button B72 is pressed, the order processing means 22 can newly create an order based on a regimen different from the first course by transmitting the regimen list screen P1 shown in FIG. 3 to the terminal device 3. it can.

Here, the overlap between courses defined by the regimen information will be described.
The regimen master information stored in the storage unit 24 of the processing server 2 includes a setting as to whether or not duplication is permitted when regimen courses are duplicated. This is determined by the combination of anticancer drugs that are drugs administered to the patient.
The contents of the regimen master information can be referred to from the regimen list screen P1 shown in FIG. For example, in the terminal device 3 on which the regimen list screen P1 shown in FIG. 3 is displayed, the regimen reference screen P9 shown in FIG. 12 is displayed by pressing the regimen reference button B14 after selecting the regimen by operating the input means. It is transmitted from the processing server 2 to the terminal device 3.

  The regimen reference screen P9 is a screen when the regimen name “Weekly docetaxel” is selected, and shows administration information defined in the regimen master information. When “registration duplication” in the duplication setting display portion H91 on the regimen reference screen P9 is referred to, “non-duplication” is displayed. Thus, “Weekly docetaxel” indicates that duplication with any other regimen course (medication period and drug holiday) is not allowed.

For example, the regimen reference screen P10 shown in FIG. 13 displays the regimen name “medullary note” by the same operation as “Weekly docetaxel”. According to this regimen reference screen P10, the regimen name “medullary note” is displayed as “overlap possible” when referring to “repeated regimen” in the duplicate setting display section H91.
Therefore, the order processing means 22 can register even if the course period of the regimen name “medullary note” is set so as to overlap the medication period or drug withdrawal period after registering another regimen.

Furthermore, the regimen reference screen P11 shown in FIG. 14 displays the regimen name “Rituxan” by the same operation as “Weekly docetaxel”. According to the regimen reference screen P11, the regimen name “Rituxan” is displayed as “Duplicate allowed (limited)” when “Duplicate regimen” in the duplicate setting display section H91 is referred to.
“Overlapping allowed (limited)” indicates that the regimen overlapping the dosing period and the drug holiday period is limited.
A regimen that is allowed to be duplicated is operated by operating the input means of the terminal device 3 and is turned on to the duplication setting display portion H91, whereby a duplication possible regimen display portion H92 that is a list of regimens that can be duplicated is displayed.
The doctor can know in advance the regimen in which duplication is allowed by displaying the duplicatable regimen display unit H92.

This is due to duplication information included in the regimen master information stored in the storage means 24. For example, as illustrated in FIG. 15, duplication information is associated with duplication availability information and duplication regime information.
The duplication possibility information is information indicating whether or not a combination with another anticancer agent different from the anticancer agent used in the regimen information is allowed. In the present embodiment, the duplication availability information is allowed to be duplicated if it is a limited regimen such as “duplication allowed” that allows duplication with all other regimens, “no duplication allowed” that does not allow duplication. There are three types of “Limited”.
If the duplication permission / inhibition information is “limited”, a regimen that allows duplication is stored as duplication regimen information.

  By referring to the duplication information, the order processing means 22 allows duplication, non-duplication, and duplication allowed in the duplication setting display portion H91 and duplication possibility regimen display portion H92 as shown in FIGS. The regimen can be displayed.

For example, when a period overlapping with another regimen is set in the administration start date setting field R31 of the regimen confirmation screen P3 shown in FIG. 5, the order processing means 22 refers to the duplicate information.
Then, the order processing means 22 displays a warning message screen indicating that the periods are duplicated on the condition that “duplication is not allowed” or “limited” and the regimen to be duplicated is not included in the duplicate regimen information. P12 (see FIG. 16) is transmitted to the terminal device 3.
By doing so, since the doctor who operates the terminal device 3 can recognize that the duplication of the regimen has occurred and the duplication of the regimen is not allowed on the warning message screen P12, the duplication of the regimens is not allowed. When it occurs, it can be accurately judged without depending on the memory and experience of a doctor. Therefore, even if the regimen is not accurately grasped, it is possible to devise an administration schedule.

  In the present embodiment, information for identifying three types of information indicating whether or not duplication possibility information permits the duplication of courses (medication period and drug withdrawal period), or limits the regimen that allows duplication. However, it may be possible to set six states, such as whether or not the medication periods can be overlapped, whether or not the drug holiday periods can be overlapped, and whether or not the overlap is allowed.

That is, if the dosing periods can be overlapped, there are two types, that is, the dosing periods can be overlapped in all regimens and the dosing periods cannot be overlapped in all regimens.
In addition, if there is a possibility of repetition of the drug holiday period, there are two types, that is, the drug holiday period can be duplicated in all regimens and the drug holiday period cannot be duplicated in all regimens.
Furthermore, when it is limited to the case where duplication is allowed, there are two types indicating that there are regimens that allow the dosing periods to overlap and that there are regimens that allow the dosing periods to overlap.
By using such duplication permission / inhibition information, six states can be expressed and detailed settings can be made.

Next, the registered regimen can be displayed in a calendar format from the administration schedule screen P4 shown in FIG. 7, and the effective date for administering the drug can be changed.
On the administration schedule screen P4, the change button B42 displayed as “Day movement” is pressed. When the change button B42 is pressed, the schedule processing unit 23 of the processing server 2 reads the registered registration regimen information from the storage unit 24 and displays the course contents in a calendar format on the Day movement screen P13 (see FIG. 17). ) Is transmitted to the terminal device 3.

The Day movement screen P13 which is a calendar screen displayed on the display unit in the terminal device 3 is obtained by registering the first course and the second course of “Weekly docetaxel” as a regimen.
On this Day movement screen P13, an icon C1 that imitates a flag indicating the start of the first course and the second course is displayed. A number indicating the course number is displayed on the icon C1 imitating the flag.
On the Day movement screen P13, an icon C2 simulating an infusion bag indicating infusion is displayed on the first day (Day 1), the eighth day (Day 8), and the fifteenth day (Day 15). A number indicating the enforcement date is displayed on the icon C2.
Further, an icon C3 simulating a checkered flag indicating the end of the first course is displayed. In FIG. 17, the icon C3 is not displayed since the end of the second course is August.

Referring to the order reference screen P14 (see FIG. 18) at this time, the patient receives treatment by injection (infusion) from the outpatient on the first day, the eighth day and the fifteenth day of the enforcement date in the enforcement date display field R141. Is displayed.
However, the patient may not be able to visit the hospital on the day of treatment due to the circumstances of the patient. For example, when the patient cannot go to the hospital on the 8th day but can go to the hospital on the 9th day, the doctor drags the icon C2 displayed on the 8th day of the Day moving screen P13 shown in FIG. Drop on the 9th day (Day 9).

By this operation by the doctor, the effective date shift is requested from the terminal device 3 to the processing server 2. In the processing server 2, the schedule processing unit 23 transmits a confirmation screen P <b> 15 shown in FIG. 19 to the terminal device 3.
In the confirmation screen P15, buttons B151 and B152 (radio buttons) for selecting whether to move only injection (infusion) or both injection and prescription (internal medicine) as the date movement, and the schedule after the movement date Buttons B153 and B154 (radio buttons) for selecting whether or not to shift are displayed.
Since “Weekly docetaxel” is only an infusion, the doctor designates the movement of only the injection (infusion) by pressing the button B151. In addition, since the doctor does not shift the schedule after the moving target date, the doctor designates the button B154 by pressing it. Then, the user presses the move button B155 displayed as “Move”.

When the push of the move button B155 is notified from the terminal device 3 to the processing server 2, the schedule processing means 23 indicates that the enforcement date before movement (day 8 (Day 8)) is the enforcement date after movement (day 9 ( The movement to Day 9) is stored in the storage means 24. Then, the schedule processing means 23 moves the icon C2 indicating the infusion on the 8th day (Day 8) to the 9th day (Day 9), and the icon C2 and the infusion The shape indicating the date and the number indicating the effective date are the same, but a day moving screen P16 (see FIG. 20) in which the icon C4 of a different color displays the eighth day (Day 8).
At this time, referring to the order reference screen P17 shown in FIG. 21, “Day 8 (9th day)” is displayed in the effective date display field R171, and the injection (infusion) scheduled to be performed on Day8 is displayed on the 9th day. You can see that it has changed.

In this way, on the Day movement screens P13 and P16, when it is desired to move the effective date of medication to the effective date of the movement destination, it can be easily moved by drag and drop. Moreover, since the icon which shows having moved the enforcement date remains as a history on the enforcement day before a movement, both the enforcement date before a movement and the enforcement date after a movement can be confirmed.
In addition, on the order reference screens P14 and P17, the enforcement date after the move is displayed in the enforcement date column before the move, and the enforcement date before the move remains as a history, so the enforcement date before the move and the enforcement date after the move Both day and day can be confirmed.

  Therefore, the doctor can determine at a glance when the effective date after the movement has moved.

In the confirmation screen P15 shown in FIG. 19, the schedule after the movement target date is not shifted, but the schedule after the movement target date may be shifted according to the condition of the patient.
In this case, on the confirmation screen P15 shown in FIG. 19, the doctor selects the button B153 displayed as “Yes” for “Subsequent Day movement”, and presses the movement button B155 displayed as “Move”. To do.
Then, the schedule processing means 23 shifts not only the medication period of the course including the effective date of the movement object but also the drug withdrawal period after the medication period, so the next course is also sequentially shifted. .
In this way, when the effective date of the movement target is moved, the course including the effective date of the moving object is shifted, and the next course is also sequentially shifted. The administration schedule can be easily changed without relying on manual calculation by the doctor such as the next course implementation date and the course end date.

At this time, depending on the setting, the dosing period may be shifted, but the drug withdrawal period may not be shifted. By doing so, the next course can be implemented as scheduled.
However, if the regimen requires a prescribed withdrawal period, the dosing period will be shifted, but if the withdrawal period is not shifted, the course that includes the effective date of the movement and the next The course overlaps.
In this case, the order processing means 22 may determine the overlap between courses.

  The present invention is suitable for a medical institution to which a doctor who performs cancer treatment using an anticancer agent belongs.

DESCRIPTION OF SYMBOLS 1 Chemotherapy support system 2 Processing server 21 Communication means 22 Order processing means 23 Schedule processing means 24 Storage means 3 Terminal device H Hospital P1 Regimen list screen R11 Large classification field R12 Small classification field B11 New history combined button B12 List display button B13 Regimen Confirmation button B14 Regimen reference button P2 Regimen confirmation screen R21 Physique information selection field R22 Regimen comment display field R23 Recipe display field R24 Course times designation field B2 Regimen order button P3 Regimen order screen R31 Administration start date setting field R32 Recipe display field S31 Dose setting Part S32 Dose setting part B31 Regem master conform button B32 Administration schedule button P31 Warning message screen P4 Administration schedule screen R41 Recipe details field B41 Order registration button B42 Change button P5 Order registration confirmation screen B51 OK button B52 Cancel button P6 Order registration completion screen P7 Course history screen B71 Copy button B72 New order button P8 Regimen confirmation screen R81 Course times designation field B8 Regimen order buttons P9, P10, P11 Regimen reference screen H91 Duplicate setting display portion H92 Duplicatable regimen display portion P12 Warning message screen P13 Day move screen C1 to C3 icon P14 Order reference screen R141 Effective date display field P15 Confirmation screen B151 to B154 button B155 Move button P16 Day move screen P17 Order reference screen R171 Effective date display field

Claims (3)

The type of anticancer drug administered to a patient, regimen information indicating a standard dosage and a regimen including a dosage schedule, and duplication indicating whether a combination with another anticancer drug different from the anticancer drug used in the regimen information is allowed Storage means for storing regimen master information including information;
Whether or not to allow duplication based on the duplication information when a combination with other anticancer agents occurs during the period of the administration schedule specified by the regimen information when a regimen order is created based on the regimen information The chemotherapy support apparatus provided with the order processing means to determine.   The duplication information includes whether or not duplication with all other regimens is permitted, or duplication availability information indicating that duplication with the regimen is selectively permitted, and the duplication availability information is selectively The chemotherapy support apparatus according to claim 1, further comprising duplication regimen information indicating a regimen in which duplication is allowed in a case where duplication is allowed. Computer
The type of anticancer drug administered to a patient, regimen information indicating a standard dosage and a regimen including a dosage schedule, and duplication indicating whether a combination with another anticancer drug different from the anticancer drug used in the regimen information is allowed Storage means for storing regimen master information including information;
Whether or not to allow duplication based on the duplication information when a combination with other anticancer agents occurs during the period of the administration schedule specified by the regimen information when a regimen order is created based on the regimen information Chemotherapy support program that functions as an order processing means to determine